Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03749746 · ClinicalTrials.gov registry record · NA
Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia
A NA study of Obesity and Hypertension, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
- 1
- Study location
NCT03749746: Completed NA study of Obesity and Hypertension, sponsored by University of Pittsburgh.
NCT03749746 is a NA study of Obesity and Hypertension that has completed, run by University of Pittsburgh. The registered enrollment target is 148 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03749746, a NA study of Obesity and Hypertension, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
- 1
- Study location
Study Summary
Preeclampsia causes devastating maternal and neonatal morbidity and mortality with a high recurrence risk and a rapid, occult progression to cardiovascular disease after delivery. There is a critical need for effective interventions to reduce these risks. This is a pilot randomized controlled trial of a novel postpartum lifestyle intervention compared to women who take home blood pressure measurements and women with usual care who are overweight and obese in the first year after preeclampsia. The investigators hypothesize that the intervention will lead to improved weight loss and blood pressure in the first year postpartum, which has broad implications for future pregnancy and long-term cardiovascular health.
Primary Outcome
weight change between two study visits
Conditions Studied
Interventions
- OTHER Usual care
- BEHAVIORAL Home Blood Pressure Monitoring
- BEHAVIORAL Heart Health 4 New Moms
Study Locations (1)
Pennsylvania
- University of Pittsburgh Magee-Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2019-01-26 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
What the finished NCT03749746 record still lists
NCT03749746 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower).
The record links to 8 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Usual care is the first listed.
NCT03749746 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03749746 about?
NCT03749746 is a clinical study titled "Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia". Preeclampsia causes devastating maternal and neonatal morbidity and mortality with a high recurrence risk and a rapid, occult progression to cardiovascular disease after delivery. There is a critical need for effective interventions to reduce these risks. This is a pilot randomized controlled trial ...
What is the current status of trial NCT03749746?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2019-01-26. Estimated completion is 2021-12-01.
What conditions does trial NCT03749746 study?
This clinical trial studies the following conditions: Obesity, Hypertension, Overweight and Obesity, Preeclampsia, Pregnancy Complications.
What interventions are being tested in trial NCT03749746?
The interventions under investigation include: Usual care (OTHER), Home Blood Pressure Monitoring (BEHAVIORAL), Heart Health 4 New Moms (BEHAVIORAL).
Who is sponsoring clinical trial NCT03749746?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03749746 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03749746's enrollment target sits among peer trials
148 389th of 1053 higher than 664 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
- NCT04639297 · 148 participants · NA
NeuroVision vs Standard Neuromonitoring
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI